Abstract
In the past, accelerated tryptophan breakdown was considered to be a feature of clinical conditions, such as infection, inflammation, and malignant disease. More recently, however, the focus has changed to include the additional modulation of tryptophan metabolism by changes in nutrition and microbiota composition. The regulation of tryptophan concentration is critical for the maintenance of systemic homeostasis because it integrates essential pathways involved in nutrient sensing, metabolic stress response, and immunity. In addition to tryptophan being important as a precursor for the synthesis of the neurotransmitter serotonin, several catabolites along the kynurenine axis are neuroactive. This emphasizes the importance of the immunometabolic fate of this amino acid for processes relevant to neuropsychiatric symptoms. In humans, besides hepatic catabolism, there is usually a strong relationship between immune activation-associated tryptophan breakdown and increased levels of biomarkers, such as neopterin, which has particular relevance for both acute and chronic diseases. A shift towards neopterin synthesis during oxidative stress may indicate a corresponding decrease in tetrahydrobiopterin, a cofactor of several mono-oxygenases, providing a further link between tryptophan metabolism and serotonergic and catecholaminergic neurotransmission. The psychoneuroimmunological consequences of tryptophan metabolism and the susceptibility of this pathway to modulation by a variety of nutritional and lifestyle-related factors have important implications for the development of both diagnostic and treatment options.
References
1.
Fukui
S
, Schwarcz
R
, Rapoport
SI
, Takada
Y
, Smith
QR
. Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism
. J Neurochem
. 1991
Jun
;56
(6
):2007
–17
.
[PubMed]
0022-30422.
Schröcksnadel
K
, Wirleitner
B
, Winkler
C
, Fuchs
D
. Monitoring tryptophan metabolism in chronic immune activation
. Clin Chim Acta
. 2006
Feb
;364
(1-2
):82
–90
.
[PubMed]
0009-89813.
Dantzer
R
. Role of the Kynurenine Metabolism Pathway in Inflammation-Induced Depression: preclinical Approaches
. Curr Top Behav Neurosci
. 2017
;31
:117
–38
.
[PubMed]
1866-33704.
Myint
AM
, Schwarz
MJ
, Müller
N
. The role of the kynurenine metabolism in major depression
. J Neural Transm (Vienna)
. 2012
Feb
;119
(2
):245
–51
.
[PubMed]
0300-95645.
Müller
N
. Immunology of major depression
. Neuroimmunomodulation
. 2014
;21
(2-3
):123
–30
.
[PubMed]
1021-74016.
Stone
TW
, Mackay
GM
, Forrest
CM
, Clark
CJ
, Darlington
LG
. Tryptophan metabolites and brain disorders
. Clin Chem Lab Med
. 2003
Jul
;41
(7
):852
–9
.
[PubMed]
1434-66217.
Stone
TW
, Darlington
LG
. Endogenous kynurenines as targets for drug discovery and development
. Nat Rev Drug Discov
. 2002
Aug
;1
(8
):609
–20
.
[PubMed]
1474-17768.
Widner
B
, Ledochowski
M
, Fuchs
D
. Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences
. Curr Drug Metab
. 2000
Sep
;1
(2
):193
–204
.
[PubMed]
1389-20029.
Stone
TW
, Darlington
LG
. The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders
. Br J Pharmacol
. 2013
Jul
;169
(6
):1211
–27
.
[PubMed]
0007-118810.
Gostner
J
, Ciardi
C
, Becker
K
, Fuchs
D
, Sucher
R
. Immunoregulatory impact of food antioxidants
. Curr Pharm Des
. 2014
;20
(6
):840
–9
.
[PubMed]
1381-612811.
Strasser
B
, Fuchs
D
. Diet Versus Exercise in Weight Loss and Maintenance: focus on Tryptophan
. Int J Tryptophan Res
. 2016
May
;9
:9
–16
.
[PubMed]
1178-646912.
Notarangelo
FM
, Pocivavsek
A
, Schwarcz
R
. Exercise Your Kynurenines to Fight Depression
. Trends Neurosci
. 2018
Aug
;41
(8
):491
–3
.
[PubMed]
0166-223613.
Gao
J
, Xu
K
, Liu
H
, Liu
G
, Bai
M
, Peng
C
, et al. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
. Front Cell Infect Microbiol
. 2018
Feb
;8
:13
.
[PubMed]
2235-298814.
Pfefferkorn
ER
. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan
. Proc Natl Acad Sci USA
. 1984
Feb
;81
(3
):908
–12
.
[PubMed]
0027-842415.
Yoshida
R
, Imanishi
J
, Oku
T
, Kishida
T
, Hayaishi
O
. Induction of pulmonary indoleamine 2,3-dioxygenase by interferon
. Proc Natl Acad Sci USA
. 1981
Jan
;78
(1
):129
–32
.
[PubMed]
0027-842416.
Werner
ER
, Hirsch-Kauffmann
M
, Fuchs
D
, Hausen
A
, Reibnegger
G
, Schweiger
M
, et al. Interferon-gamma-induced degradation of tryptophan by human cells in vitro
. Biol Chem Hoppe Seyler
. 1987
Oct
;368
(10
):1407
–12
.
[PubMed]
0177-359317.
Fuchs
D
, Möller
AA
, Reibnegger
G
, Werner
ER
, Werner-Felmayer
G
, Dierich
MP
, Wachter
H
. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection.
Immunol Lett. 1991
;28):207-211. 18.
Fallarino
F
, Grohmann
U
, Vacca
C
, Bianchi
R
, Orabona
C
, Spreca
A
, et al. T cell apoptosis by tryptophan catabolism
. Cell Death Differ
. 2002
Oct
;9
(10
):1069
–77
.
[PubMed]
1350-904719.
Brandacher
G
, Perathoner
A
, Ladurner
R
, Schneeberger
S
, Obrist
P
, Winkler
C
, et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells
. Clin Cancer Res
. 2006
Feb
;12
(4
):1144
–51
.
[PubMed]
1078-043220.
Weinlich
G
, Murr
C
, Richardsen
L
, Winkler
C
, Fuchs
D
. Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients
. Dermatology
. 2007
;214
(1
):8
–14
.
[PubMed]
1018-866521.
Pedersen
ER
, Midttun
Ø
, Ueland
PM
, Schartum-Hansen
H
, Seifert
R
, Igland
J
, et al. Systemic markers of interferon-γ-mediated immune activation and long-term prognosis in patients with stable coronary artery disease
. Arterioscler Thromb Vasc Biol
. 2011
Mar
;31
(3
):698
–704
.
[PubMed]
1079-564222.
Murr
C
, Grammer
TB
, Kleber
ME
, Meinitzer
A
, Böhm
BO
, März
W
, et al. Low serum free tryptophan is associated with immune activation, inflammation and predicts mortality in patients with cardiovascular disease, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
. Eur J Clin Invest
. 2015
;45
:247
–54
.
[PubMed]
0014-297223.
Peters
JC
. Tryptophan nutrition and metabolism: an overview
. Adv Exp Med Biol
. 1991
;294
:345
–58
.
[PubMed]
0065-259824.
Chen
Y
, Guillemin
GJ
. Kynurenine pathway metabolites in humans: disease and healthy States
. Int J Tryptophan Res
. 2009
;2
:1
–19
.
[PubMed]
1178-646925.
Coppen
A
, Shaw
DM
, Herzberg
B
, Maggs
R
. Tryptophan in the treatment of depression
. Lancet
. 1967
Dec
;2
(7527
):1178
–80
.
[PubMed]
0140-673626.
Hertz
D
, Sulman
FG
. Preventing depression with tryptophan
. Lancet
. 1968
Mar
;1
(7541
):531
–2
.
[PubMed]
0140-673627.
Fuchs
D
, Möller
AA
, Reibnegger
G
, Stöckle
E
, Werner
ER
, Wachter
H
. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms
. J Acquir Immune Defic Syndr
. 1990
;3
(9
):873
–6
.
[PubMed]
0894-925528.
Perkins
MN
, Stone
TW
. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid
. Brain Res
. 1982
Sep
;247
(1
):184
–7
.
[PubMed]
0006-899329.
Stone
TW
, Perkins
MN
. Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS
. Eur J Pharmacol
. 1981
Jul
;72
(4
):411
–2
.
[PubMed]
0014-299930.
Schwarcz
R
, Whetsell
WO
Jr, Mangano
RM
. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain
. Science
. 1983
Jan
;219
(4582
):316
–8
.
[PubMed]
0036-807531.
Schwarcz
R
, Bruno
JP
, Muchowski
PJ
, Wu
HQ
. Kynurenines in the mammalian brain: when physiology meets pathology
. Nat Rev Neurosci
. 2012
Jul
;13
(7
):465
–77
.
[PubMed]
1471-003X32.
Weiss
G
, Diez-Ruiz
A
, Murr
C
, Terul
I
, Fuchs
D
. Tryptophan metabolites as scavengers of reactive oxygen and chlorine species
. Pteridines
. 2002
;13
(4
):140
–4
. 0933-480733.
Lardy
HA
. The role of tryptophan metabolites in regulating gluconeogenesis
. Am J Clin Nutr
. 1971
Jul
;24
(7
):764
–5
.
[PubMed]
0002-916534.
Fernstrom
JD
, Wurtman
RJ
. Brain serotonin content: physiological regulation by plasma neutral amino acids
. Science
. 1972
Oct
;178
(4059
):414
–6
.
[PubMed]
0036-807535.
Walker
AK
, Wing
EE
, Banks
WA
, Dantzer
R
. Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice
. Mol Psychiatry
. Forthcoming 2018
Jul
.
[PubMed]
1359-418436.
Kita
T
, Morrison
PF
, Heyes
MP
, Markey
SP
. Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain
. J Neurochem
. 2002
Jul
;82
(2
):258
–68
.
[PubMed]
0022-304237.
Widner
B
, Laich
A
, Sperner-Unterweger
B
, Ledochowski
M
, Fuchs
D
. Neopterin production, tryptophan degradation, and mental depression—what is the link?
Brain Behav Immun
. 2002
Oct
;16
(5
):590
–5
.
[PubMed]
0889-159138.
Rudzite
V
, Berzinsh
J
, Grivane
I
, Fuchs
D
, Baier-Bitterlich
G
, Wachter
H
. Serum tryptophan, kynurenine, and neopterin in patients with Guillain-Barre-syndrome (GBS) and multiple sclerosis (MS)
. Adv Exp Med Biol
. 1996
;398
:183
–7
.
[PubMed]
0065-259839.
Quera Salva
MA
, Hartley
S
, Barbot
F
, Alvarez
JC
, Lofaso
F
, Guilleminault
C
. Circadian rhythms, melatonin and depression
. Curr Pharm Des
. 2011
;17
(15
):1459
–70
.
[PubMed]
1381-612840.
Li
Y
, Hu
N
, Yang
D
, Oxenkrug
G
, Yang
Q
. Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism
. FEBS J
. 2017
Mar
;284
(6
):948
–66
.
[PubMed]
1742-464X41.
Gershon
MD
, Tack
J
. The serotonin signaling system: from basic understanding to drug development for functional GI disorders
. Gastroenterology
. 2007
Jan
;132
(1
):397
–414
.
[PubMed]
0016-508542.
Wurtman
RJ
. Food consumption, neurotransmitter synthesis, and human behaviour
. Experientia Suppl
. 1983
;44
:356
–69
.
[PubMed]
0071-335X43.
Badawy
AA
. The functions and regulation of tryptophan pyrrolase
. Life Sci
. 1977
Sep
;21
(6
):755
–68
.
[PubMed]
0024-320544.
Geisler
S
, Mayersbach
P
, Becker
K
, Schennach
H
, Fuchs
D
, Gostner
J
. Serum tryptophan, kynurenine, phenylalanine, tyrosine and neopterin concentrations in 100 healthy blood donors
. Pteridines
. 2015
;26
(1
):31
–6
. 0933-480745.
Widner
B
, Werner
ER
, Schennach
H
, Wachter
H
, Fuchs
D
. Simultaneous measurement of serum tryptophan and kynurenine by HPLC
. Clin Chem
. 1997
Dec
;43
(12
):2424
–6
.
[PubMed]
0009-914746.
Capuron
L
, Geisler
S
, Kurz
K
, Leblhuber
F
, Sperner-Unterweger
B
, Fuchs
D
. Activated immune system and inflammation in healthy ageing: relevance for tryptophan and neopterin metabolism
. Curr Pharm Des
. 2014
;20
(38
):6048
–57
.
[PubMed]
1381-612847.
Werner-Felmayer
G
, Golderer
G
, Werner
ER
. Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects
. Curr Drug Metab
. 2002
Apr
;3
(2
):159
–73
.
[PubMed]
1389-200248.
Murr
C
, Widner
B
, Wirleitner
B
, Fuchs
D
. Neopterin as a marker for immune system activation
. Curr Drug Metab
. 2002
Apr
;3
(2
):175
–87
.
[PubMed]
1389-200249.
Jenny
M
, Klieber
M
, Zaknun
D
, Schroecksnadel
S
, Kurz
K
, Ledochowski
M
, et al. In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors
. Inflamm Res
. 2011
Feb
;60
(2
):127
–35
.
[PubMed]
1023-383050.
Gorren
AC
, Mayer
B
. Tetrahydrobiopterin in nitric oxide synthesis: a novel biological role for pteridines
. Curr Drug Metab
. 2002
Apr
;3
(2
):133
–57
.
[PubMed]
1389-200251.
Watschinger
K
, Keller
MA
, Golderer
G
, Hermann
M
, Maglione
M
, Sarg
B
, et al. Identification of the gene encoding alkylglycerol monooxygenase defines a third class of tetrahydrobiopterin-dependent enzymes
. Proc Natl Acad Sci USA
. 2010
Aug
;107
(31
):13672
–7
.
[PubMed]
0027-842452.
Sathyasaikumar
KV
, Tararina
M
, Wu
HQ
, Neale
SA
, Weisz
F
, Salt
TE
, et al. Xanthurenic Acid Formation from 3-Hydroxykynurenine in the Mammalian Brain: Neurochemical Characterization and Physiological Effects
. Neuroscience
. 2017
Dec
;367
:85
–97
.
[PubMed]
0306-452253.
Haruki
H
, Hovius
R
, Pedersen
MG
, Johnsson
K
. Tetrahydrobiopterin biosynthesis as a potential target of the kynurenine pathway metabolite xanthurenic acid
. J Biol Chem
. 2016
Jan
;291
(2
):652
–7
.
[PubMed]
0021-925854.
Anderson
DN
, Wilkinson
AM
, Abou-Saleh
MT
, Blair
JA
. Recovery from depression after electroconvulsive therapy is accompanied by evidence of increased tetrahydrobiopterin-dependent hydroxylation
. Acta Psychiatr Scand
. 1994
Jul
;90
(1
):10
–3
.
[PubMed]
0001-690X55.
Capuron
L
, Schroecksnadel
S
, Féart
C
, Aubert
A
, Higueret
D
, Barberger-Gateau
P
, et al. Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms
. Biol Psychiatry
. 2011
Jul
;70
(2
):175
–82
.
[PubMed]
0006-322356.
Wink
DA
, Hines
HB
, Cheng
RY
, Switzer
CH
, Flores-Santana
W
, Vitek
MP
, et al. Nitric oxide and redox mechanisms in the immune response
. J Leukoc Biol
. 2011
Jun
;89
(6
):873
–91
.
[PubMed]
0741-540057.
Thomas
SR
, Terentis
AC
, Cai
H
, Takikawa
O
, Levina
A
, Lay
PA
, et al. Post-translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide
. J Biol Chem
. 2007
Aug
;282
(33
):23778
–87
.
[PubMed]
0021-925858.
Zaknun
D
, Schroecksnadel
S
, Kurz
K
, Fuchs
D
. Potential role of antioxidant food supplements, preservatives and colorants in the pathogenesis of allergy and asthma
. Int Arch Allergy Immunol
. 2012
;157
(2
):113
–24
.
[PubMed]
1018-243859.
Gostner
JM
, Becker
K
, Ueberall
F
, Fuchs
D
. The good and bad of antioxidant foods: an immunological perspective
. Food Chem Toxicol
. 2015
Jun
;80
:72
–9
.
[PubMed]
0278-691560.
Strasser
B
, Geiger
D
, Schauer
M
, Gatterer
H
, Burtscher
M
, Fuchs
D
. Effects of Exhaustive Aerobic Exercise on Tryptophan-Kynurenine Metabolism in Trained Athletes
. PLoS One
. 2016
Apr
;11
(4
):e0153617
.
[PubMed]
1932-620361.
Gostner
JM
, Geisler
S
, Stonig
M
, Fuchs
D
. IDO-1 mediated tryptophan catabolism – a universal environmental sensing pathway. 15th International Society for Tryptophan Research (ISTRY) Conference, abstract no. P-07, Hikone, Japan, 2018
.62.
Fernstrom
JD
, Wurtman
RJ
. Brain serotonin content: increase following ingestion of carbohydrate diet
. Science
. 1971
Dec
;174
(4013
):1023
–5
.
[PubMed]
0036-807563.
Strasser
B
, Gostner
JM
, Fuchs
D
. Mood, food, and cognition: role of tryptophan and serotonin
. Curr Opin Clin Nutr Metab Care
. 2016
Jan
;19
(1
):55
–61
.
[PubMed]
1363-195064.
Jenny
M
, Schroecksnadel
S
, Fuchs
D
. Testing for immunomodulatory properties of nanoparticles
. J Biomed Nanotechnol
. 2011
Feb
;7
(1
):11
–2
.
[PubMed]
1550-703365.
Murr
C
, Winklhofer-Roob
BM
, Schroecksnadel
K
, Maritschnegg
M
, Mangge
H
, Böhm
BO
, et al. Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease
. Atherosclerosis
. 2009
Feb
;202
(2
):543
–9
.
[PubMed]
0021-915066.
Gualdoni
GA
, Fuchs
D
, Zlabinger
GJ
, Gostner
JM
. Resveratrol intake enhances indoleamine-2,3-dioxygenase activity in humans
. Pharmacol Rep
. 2016
Oct
;68
(5
):1065
–8
.
[PubMed]
1734-114067.
Wirleitner
B
, Schroecksnadel
K
, Winkler
C
, Schennach
H
, Fuchs
D
. Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro
. Immunol Lett
. 2005
Sep
;100
(2
):159
–63
.
[PubMed]
0165-247868.
Gostner
JM
, Becker
K
, Croft
KD
, Woodman
RJ
, Puddey
IB
, Fuchs
D
, et al. Regular consumption of black tea increases circulating kynurenine concentrations: A randomized controlled trial
. BBA Clin
. 2014
Dec
;3
:31
–5
.
[PubMed]
2214-647469.
Zvetkova
E
, Wirleitner
B
, Tram
NT
, Schennach
H
, Fuchs
D
. Aqueous extracts of Crinum latifolium (L.) and Camellia sinensis show immunomodulatory properties in human peripheral blood mononuclear cells
. Int Immunopharmacol
. 2001
Nov
;1
(12
):2143
–50
.
[PubMed]
1567-576970.
Laurans
L
, Venteclef
N
, Haddad
Y
, Chajadine
M
, Alzaid
F
, Metghalchi
S
, et al. Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health
. Nat Med
. 2018
Aug
;24
(8
):1113
–20
.
[PubMed]
1078-895671.
Zelante
T
, Iannitti
RG
, Cunha
C
, De Luca
A
, Giovannini
G
, Pieraccini
G
, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22
. Immunity
. 2013
Aug
;39
(2
):372
–85
.
[PubMed]
1074-761372.
Cryan
JF
, Dinan
TG
. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
. Nat Rev Neurosci
. 2012
Oct
;13
(10
):701
–12
.
[PubMed]
1471-003X73.
Strasser
B
, Geiger
D
, Schauer
M
, Gostner
JM
, Gatterer
H
, Burtscher
M
, et al. Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial
. Nutrients
. 2016
Nov
;8
(11
):E752
.
[PubMed]
2072-664374.
Horvath
A
, Leber
B
, Schmerboeck
B
, Tawdrous
M
, Zettel
G
, Hartl
A
, et al. Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis
. Aliment Pharmacol Ther
. 2016
Nov
;44
(9
):926
–35
.
[PubMed]
0269-281375.
Leblhuber
F
, Steiner
K
, Schuetz
B
, Fuchs
D
, Gostner
JM
. Probiotic Supplementation in Patients with Alzheimer’s Dementia - An Explorative Intervention Study
. Curr Alzheimer Res
. 2018
;15
(12
):1106
–13
.
[PubMed]
1567-205076.
Sharon
G
, Sampson
TR
, Geschwind
DH
, Mazmanian
SK
. The Central Nervous System and the Gut Microbiome
. Cell
. 2016
Nov
;167
(4
):915
–32
.
[PubMed]
0092-867477.
Köhler
CA
, Maes
M
, Slyepchenko
A
, Berk
M
, Solmi
M
, Lanctôt
KL
, et al. The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer’s Disease
. Curr Pharm Des
. 2016
;22
(40
):6152
–66
.
[PubMed]
1381-612878.
de Lucas
RD
, Caputo
F
, Mendes de Souza
K
, Sigwalt
AR
, Ghisoni
K
, Lock Silveira
PC
, et al. Increased platelet oxidative metabolism, blood oxidative stress and neopterin levels after ultra-endurance exercise
. J Sports Sci
. 2014
;32
(1
):22
–30
.
[PubMed]
0264-041479.
Lewis
GD
, Farrell
L
, Wood
MJ
, Martinovic
M
, Arany
Z
, Rowe
GC
, et al. Metabolic signatures of exercise in human plasma
. Sci Transl Med
. 2010
May
;2
(33
):33ra37
.
[PubMed]
1946-623480.
Agudelo
LZ
, Femenía
T
, Orhan
F
, Porsmyr-Palmertz
M
, Goiny
M
, Martinez-Redondo
V
, et al. Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression
. Cell
. 2014
Sep
;159
(1
):33
–45
.
[PubMed]
0092-867481.
Buyuktiryaki
B
, Sahiner
UM
, Girgin
G
, Birben
E
, Soyer
OU
, Cavkaytar
O
, et al. Low indoleamine 2,3-dioxygenase activity in persistent food allergy in children
. Allergy
. 2016
Feb
;71
(2
):258
–66
.
[PubMed]
0105-453882.
Ciprandi
G
, De Amici
M
, Tosca
M
, Fuchs
D
. Tryptophan metabolism in allergic rhinitis: the effect of pollen allergen exposure
. Hum Immunol
. 2010
Sep
;71
(9
):911
–5
.
[PubMed]
0198-885983.
Gostner
JM
, Becker
K
, Kofler
H
, Strasser
B
, Fuchs
D
. Tryptophan Metabolism in Allergic Disorders
. Int Arch Allergy Immunol
. 2016
;169
(4
):203
–15
.
[PubMed]
1018-243884.
Ciprandi
G
, De Amici
M
, Tosca
M
, Alesina
R
, Marseglia
G
, Fuchs
D
. Serotonin in allergic rhinitis: a possible role for behavioural symptoms
. Iran J Allergy Asthma Immunol
. 2011
Sep
;10
(3
):183
–8
.
[PubMed]
1735-150285.
Mangge
H
, Freytag
F
, Almer
G
, Weghuber
D
, Bauer-Denk
C
, Fuchs
D
. Serum neopterin is not increased in obese juveniles
. J Obes
. 2011
;2011
:946795
.
[PubMed]
2090-070886.
Mangge
H
, Summers
KL
, Meinitzer
A
, Zelzer
S
, Almer
G
, Prassl
R
, et al. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome
. Obesity (Silver Spring)
. 2014
Jan
;22
(1
):195
–201
.
[PubMed]
1930-738187.
Murr
C
, Grammer
TB
, Meinitzer
A
, Kleber
ME
, März
W
, Fuchs
D
. Immune activation and inflammation in patients with cardiovascular disease are associated with higher phenylalanine to tyrosine ratios: the ludwigshafen risk and cardiovascular health study
. J Amino Acids
. 2014
;2014
:783730
.
[PubMed]
2090-010488.
Ciprandi
G
, Fuchs
D
. Tryptophan metabolic pathway, airway nitric oxide, and allergy
. Ann Allergy Asthma Immunol
. 2017
Nov
;119
(5
):395
–6
.
[PubMed]
1081-120689.
Miller
HL
, Delgado
PL
, Salomon
RM
, Licinio
J
, Barr
LC
, Charney
DS
. Acute tryptophan depletion: a method of studying antidepressant action
. J Clin Psychiatry
. 1992
Oct
;53
Suppl
:28
–35
.
[PubMed]
0160-668990.
Biskup
CS
, Gaber
T
, Helmbold
K
, Bubenzer-Busch
S
, Zepf
FD
. Amino acid challenge and depletion techniques in human functional neuroimaging studies: an overview
. Amino Acids
. 2015
Apr
;47
(4
):651
–83
.
[PubMed]
0939-445191.
Stewart
RM
, Hood
SD
, Rao
P
, Moore
JK
, Runions
KC
, Murphy
SE
, et al. Using acute tryptophan depletion to investigate predictors of treatment response in adolescents with major depressive disorder: study protocol for a randomised controlled trial
. Trials
. 2018
Aug
;19
(1
):434
.
[PubMed]
1745-6215© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
